[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"attention-deficithyperactivity-disorderadhd\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:attention-deficithyperactivity-disorderadhd":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100641452","smartphone-based-intervention-for-young-adults-with-adhd-100641452",false,"NCT07654205","Smartphone-based Intervention for Young Adults With ADHD","Training Inhibitory Control Using Personalized Strategies (TIPS): A Randomized Controlled Feasibility Trial of a Smartphone-Based Intervention for Alcohol Use in Young Adults With ADHD","Inclusion Criteria:\n\n* Age 18-25\n* Current diagnosis of Attention Deficit\u002FHyperactivity Disorder-Combined Type according to the Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition (DSM 5)\n* Drinks at least 4 (for females) \u002F 5 (for males) alcoholic drinks in a single drinking session at least once per week\n* Owns a smartphone\n* Reads and understands English\n\nExclusion Criteria:\n\n* Currently in high school\n* Actively in treatment for Alcohol Use Disorder\n* Alcohol use disorder-severe","ALL","18 Years","25 Years",{"count":20,"type":21},70,"ESTIMATED","INTERVENTIONAL",[24],"NA","The primary goal of this clinical trial is to test if a smartphone-based intervention is feasible \\& acceptable among young adults with ADHD who also engage in risky drinking behaviors. A secondary aim is to test preliminary intervention efficacy. The main questions it aims to answer are:\n\nIs the smartphone intervention feasible \\& acceptable for participants (e.g., are they responding regularly, is there a low level of burden reported)?\n\nDoes the smartphone intervention improve symptom awareness, inhibitory control, and problematic alcohol use?\n\nParticipants will:\n\nAttend a virtual baseline visit to assess ADHD, alcohol use, and other life experiences.\n\nComplete either the TIPS smartphone intervention or a control smartphone protocol over the course of 31-days, starting the first Friday after the baseline visit.\n\nAttend a virtual follow-up visit, where many of the same questions from the baseline visit will be asked again.",[27,28],"Attention Deficit\u002FHyperactivity Disorder(ADHD)","Alcohol Use","RECRUITING","2026-06-12",{"date":32,"type":33},"2026-06-17","ACTUAL",{"date":35,"type":21},"2026-06",{"date":37,"type":21},"2027-05-01",{"name":39,"class":40},"Traci Kennedy","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":22,"phases":53,"briefSummary":47,"conditions":54,"keywords":55,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":4},"100641623","efficacy-of-transcranial-direct-current-stimulation-tdcs-in-the-treatment-of-adult-attention-deficithyperactivity-disorder-adhd-100641623","NCT07652788","Efficacy of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention-Deficit\u002FHyperactivity Disorder (ADHD)","Efficacy of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention-Deficit\u002FHyperactivity Disorder (ADHD): A Randomized Double-Blind Controlled Trial","TDACS","Inclusion Criteria:\n\n* Adult patient aged 18 to 60 years inclusive\n* Patient diagnosed with Attention-Deficit\u002FHyperactivity Disorder (ADHD), combined or predominantly inattentive presentation, previously established by a healthcare professional\n* Patients must be registered in the active caseload of the Adult Neurodevelopmental Disorders Unit (STNDA)\n* Stable psychotropic medication regimen for at least four weeks prior to inclusion, in terms of both molecule and dosage, particularly for methylphenidate, or no current psychotropic treatment. Medication must remain unchanged throughout study participation, unless medically justified changes are required\n* Patient with a cognitive status deemed sufficient by the unit's referring psychiatrist to ensure appropriate completion of the scales and tests included in the protocol\n* Free, informed, and written consent\n\nExclusion Criteria:\n\n•General condition impairment (severe fatigue or marked weakness, convalescence after an acute illness or surgery, or recent alcohol consumption)\n\nPsychiatric and neurological disorders\n\n* Diagnosis of Autism Spectrum Disorder (ASD)\n* Diagnosis of personality disorder (Cluster A, B, C, or other), according to DSM-5-TR\n* Diagnosis of schizophrenia spectrum disorder or other psychotic disorders according to DSM-5-TR\n* Diagnosis of bipolar disorder with manic episode or history of manic episodes according to DSM-5-TR\n* Confirmed neurological disorder\n* Epilepsy or history of epileptic seizures\n\nMedical comorbidities\n\n* Patient with known or suspected cardiac disease\n* Patient with severe pulmonary disease\n* Patient with cerebrovascular disease (e.g., stroke)\n\nDermatological and surgical contraindications\n\n* Patient with scalp lesions, open wounds, or skin conditions (severe acne, herpes, burns, skin fissures)\n* Patient with severe dermatitis, oozing eczema, or fragile scalp\n* Patient with major surgical scars\n* Patient with recent craniotomy\n\nImplantable devices and materials\n\n• Patient with a pacemaker or intracranial electrodes, presence of intracranial metal, or skull defects (e.g., post-craniectomy or trepanation without reconstruction)\n\nOther criteria:\n\n* Simultaneous participation in another non-pharmacological intervention provided in the STNDA day hospital (e.g., psychoeducation, cognitive remediation, body expression therapy, emotional regulation training)\n* Patient with non-pathological ASRS screening scores (fewer than 4 of the first 6 items rated \"Very often\")\n* Insufficient proficiency in the French language\n* Patient under legal guardianship, curatorship, or judicial protection\n* Pregnant or breastfeeding patient (based on clinical interview)","60 Years",{"count":52,"type":21},40,[24],[27],[56,57,58],"stimulation;","transcranial direct current stimulation (tDCS)","Échelle ASRS","NOT_YET_RECRUITING","2026-06-11",{"date":32,"type":33},{"date":63,"type":21},"2026-06-01",{"date":65,"type":21},"2028-02-20",{"name":67,"class":40},"Centre Hospitalier St Anne"]